학술논문

Safety and efficacy of twice daily versus every 8 hour Telaprevir with peginterferon/ribavirin (PR) in patients with cirrhosis
Document Type
Academic Journal
Source
Journal of Gastroenterology and Hepatology. Oct 01, 2013 28 Supp 2:167-168
Subject
Language
English
ISSN
0815-9319